Opinion - (2025) Volume 16, Issue 1
Received: 02-Feb-2025, Manuscript No. jtse-25-172356;
Editor assigned: 04-Feb-2025, Pre QC No. P-172356;
Reviewed: 18-Feb-2025, QC No. Q-172356;
Revised: 24-Feb-2025, Manuscript No. R-172356;
Published:
28-Feb-2025
, DOI: 10.37421/2157-7552.2025.16.412
Citation: Martins, Sofia. ”Stem Cells: Revolutionizing Diverse Medical Treatment.” J Tissue Sci Eng 16 (2025):412.
Copyright: © 2025 Martins S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
This article explores the use of stem cell therapy as a promising treatment for osteoarthritis, highlighting recent advancements in clinical trials and understanding of their mechanisms, including anti-inflammatory, immunomodulatory, and regenerative properties. It also discusses challenges like standardization and long-term efficacy [1].
This review summarizes the latest progress in stem cell-based therapies for spinal cord injury, focusing on various stem cell types, their therapeutic mechanisms, and outcomes from preclinical and clinical studies. It addresses current limitations and future directions for enhancing recovery [2].
This article provides an overview of the current state and future prospects of stem cell therapy in treating cardiovascular diseases. It examines different stem cell types, their mechanisms of action in myocardial repair and regeneration, and the challenges in translating these therapies into routine clinical practice [3].
This review highlights the potential of stem cell-based therapies for various liver diseases, discussing the challenges associated with clinical translation and current progress. It covers different stem cell types and their regenerative capabilities in addressing liver injury and dysfunction [4].
This article reviews mesenchymal stem cell (MSC) therapy for inflammatory bowel disease (IBD), detailing recent advances in preclinical and clinical studies. It focuses on MSCs immunomodulatory effects, mechanisms of action, and future perspectives for improving therapeutic outcomes in IBD patients [5].
This review discusses the current challenges and opportunities in using stem cell therapy for neurodegenerative diseases. It examines the potential of various stem cell types to replace damaged neurons, provide neurotrophic support, and modulate inflammation, while acknowledging hurdles in achieving clinical success [6].
This article reviews the progress in clinical applications of stem cells for chronic kidney disease, exploring different types of stem cells and their mechanisms in kidney repair, including anti-inflammatory, anti-fibrotic, and regenerative effects. It highlights promising clinical trial outcomes and future directions [7].
This article provides insights into stem cell-based therapies for diabetes mellitus, focusing on current perspectives and future directions. It discusses the potential of various stem cell types to replace insulin-producing cells or modulate the immune system, offering hope for both type 1 and type 2 diabetes [8].
This review outlines the progress and challenges of stem cell therapy for ischemic stroke. It explores the mechanisms by which stem cells promote neuroprotection, angiogenesis, and neurogenesis, aiming to improve functional recovery after stroke, while also addressing obstacles to clinical translation [9].
This comprehensive review focuses on mesenchymal stem cell (MSC) therapy for skin wound healing. It details the mechanisms by which MSCs contribute to various phases of wound repair, including inflammation modulation, angiogenesis, and extracellular matrix remodeling, highlighting their therapeutic potential [10].
Across recent years, scientific inquiry has significantly advanced the understanding and application of stem cell therapies for a wide array of diseases.
This article explores the use of stem cell therapy as a promising treatment for osteoarthritis, highlighting recent advancements in clinical trials and understanding of their mechanisms, including anti-inflammatory, immunomodulatory, and regenerative properties. It also discusses challenges like standardization and long-term efficacy [1]. This review summarizes the latest progress in stem cell-based therapies for spinal cord injury, focusing on various stem cell types, their therapeutic mechanisms, and outcomes from preclinical and clinical studies. It addresses current limitations and future directions for enhancing recovery [2].
This article provides an overview of the current state and future prospects of stem cell therapy in treating cardiovascular diseases. It examines different stem cell types, their mechanisms of action in myocardial repair and regeneration, and the challenges in translating these therapies into routine clinical practice [3]. This review highlights the potential of stem cell-based therapies for various liver diseases, discussing the challenges associated with clinical translation and current progress. It covers different stem cell types and their regenerative capabilities in addressing liver injury and dysfunction [4].
This article reviews mesenchymal stem cell (MSC) therapy for inflammatory bowel disease (IBD), detailing recent advances in preclinical and clinical studies. It focuses on MSCs immunomodulatory effects, mechanisms of action, and future perspectives for improving therapeutic outcomes in IBD patients [5]. This review discusses the current challenges and opportunities in using stem cell therapy for neurodegenerative diseases. It examines the potential of various stem cell types to replace damaged neurons, provide neurotrophic support, and modulate inflammation, while acknowledging hurdles in achieving clinical success [6].
This article reviews the progress in clinical applications of stem cells for chronic kidney disease, exploring different types of stem cells and their mechanisms in kidney repair, including anti-inflammatory, anti-fibrotic, and regenerative effects. It highlights promising clinical trial outcomes and future directions [7]. This article provides insights into stem cell-based therapies for diabetes mellitus, focusing on current perspectives and future directions. It discusses the potential of various stem cell types to replace insulin-producing cells or modulate the immune system, offering hope for both type 1 and type 2 diabetes [8].
This review outlines the progress and challenges of stem cell therapy for ischemic stroke. It explores the mechanisms by which stem cells promote neuroprotection, angiogenesis, and neurogenesis, aiming to improve functional recovery after stroke, while also addressing obstacles to clinical translation [9]. This comprehensive review focuses on mesenchymal stem cell (MSC) therapy for skin wound healing. It details the mechanisms by which MSCs contribute to various phases of wound repair, including inflammation modulation, angiogenesis, and extracellular matrix remodeling, highlighting their therapeutic potential [10].
These collective studies highlight both the immense therapeutic potential and the ongoing challenges in translating stem cell research into widespread clinical practice.
Recent advancements in stem cell therapy are transforming treatment landscapes across various medical conditions. For osteoarthritis, stem cells exhibit anti-inflammatory, immunomodulatory, and regenerative properties, showing promise in clinical trials, though standardization and long-term efficacy remain areas of focus. Spinal cord injuries are seeing progress through diverse stem cell types and mechanisms aimed at improving recovery, with ongoing efforts to overcome current limitations. In cardiovascular diseases, different stem cell types are being investigated for myocardial repair and regeneration, pushing towards broader clinical application. Liver diseases also benefit from stem cell-based approaches, demonstrating regenerative capabilities to counter injury and dysfunction, marking significant clinical strides. Mesenchymal Stem Cell (MSC) therapy is proving effective for Inflammatory Bowel Disease (IBD) by leveraging its immunomodulatory effects. Neurodegenerative diseases pose complex challenges, yet stem cells offer potential by replacing damaged neurons, providing neurotrophic support, and modulating inflammation. Chronic kidney disease treatments are advancing, with stem cells showing anti-inflammatory, anti-fibrotic, and regenerative effects in clinical trials. Diabetes mellitus therapies are exploring stem cells to replace insulin-producing cells or modulate immune responses for both Type 1 and Type 2 cases. For ischemic stroke, stem cells promote neuroprotection, angiogenesis, and neurogenesis to enhance functional recovery, despite hurdles in clinical translation. Finally, MSC therapy provides a comprehensive approach to skin wound healing, involving inflammation modulation, angiogenesis, and extracellular matrix remodeling.
None
None
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report
